DRUG COMPARISON

After a heart transplant, patients must take drugs to prevent their body from rejecting the new organ. For years, doctors have relied on a standard mix of three medications: a calcineurin inhibitor, a drug that slows cell growth, and steroids. But now, everolimus is gaining attention as a possible r

Two treatments, sotorasib and adagrasib, have received approval in the USA and Europe for tackling advanced or metastatic non-small cell lung cancer. This type of cancer is marked by a specific mutation known as KRAS G12C. Since these treatments have not been directly compared in clinical trials, re